Prerpints.org logo
Preprint
Article

Analysis of Resin-Based Dental Materials Composition Depending on Their Clinical Applications

Altmetrics

Downloads

133

Views

43

Comments

0

A peer-reviewed article of this preprint also exists.

supplementary.pdf (152.09KB )

Submitted:

19 March 2024

Posted:

19 March 2024

You are already at the latest version

Alerts
Abstract
The objective of this study was to detail the monomer composition of resin-based dental materials sold in the market in 2023 and to evaluate the proportion of BPA derivatives in relation with their applications. A search on manufacturers’ websites was performed to reference resin-based dental materials currently on the market. Their monomer composition was determined from material safety data sheets and completed with a search on PubMed database. Among the 543 material compositions exploitable, 382 (70.3%) contained BPA derivatives. Among them, 56.2% contained BisGMA, 28% BisEMA, the most frequently reported. A total of 59 monomers of which 6 BPA-derivatives were found. 309 materials (56.9%) contained UDMA and 292 (53.8%) TEGDMA. Less than one third of materials identified contained no BPA derivatives. These proportions vary a lot depending on their applications with materials dedicated to dental care of young populations containing the highest proportions of BPA-derivatives monomers. The long-term effects on human health of the different monomers identified including BPA-derivatives monomers is a source of concern. For children and pregnant or lactating women arises the question to take a precautionary principle and avoid the use of resin-based dental materials likely to release BPA by opting for alternative materials.
Keywords: 
Subject: Medicine and Pharmacology  -   Dentistry and Oral Surgery

1. Introduction

Nowadays, resin-based dental materials are commonly used in multiple fields of dentistry with a wide range of applications: restorative dentistry with resin-based composite materials and their associated adhesive systems [1,2] or resin modified glass ionomer cements [3] to restore decayed, worn, or traumatized teeth, pediatric dentistry with pit and fissure sealants [4], orthodontics with adhesives for brackets or fixed retainers bonding [5], and prosthetic dentistry with luting cements and composites [6].
Resin-based dental materials are generally composed of an organic matrix made of oligomers and monomers with inorganic filler particles linked to the matrix through a silane coupling agent [2]. The monomers most frequently used are methacrylates. Among methacrylates, Bisphenol A glycidyl methacrylate (BisGMA) and other Bisphenol A (BPA)-derivatives monomers are the most employed because of their properties such as flexural strength, volumetric shrinkage, water sorption, solubility, and viscosity [1,2]. Other methacrylates frequently used, alone or in association with BisGMA, are not bisphenol A-derived such as Urethane dimethacrylate (UDMA), Triethylene glycol dimethacrylate (TEGDMA) or 2-hydroxyethyl methacrylate (HEMA) [1,2]. Moreover, recently, new types of resin matrix have been introduced such as ormocers and siloranes [1,2].
In recent years, the increasing presence of resin-based dental materials in oral cavity has raised questions about biocompatibility and safety of resin matrix components [1,2]. Resin-based dental materials are subjected to numerous constraints such as physical-chemical (thermal variations), mechanical (abrasion linked to oral hygiene measures and functions or parafunctions), chemical (corrosion caused by food and drinks, acid attacks or hydrolysis) or even bacteriological (bacterial enzymatic attacks) [7]. These constraints inevitably lead to their degradation and consequently the release of all or part of their components [8]. In addition, during the polymerization reaction of resin-based materials, monomers are converted into polymers mostly initiated by light-curing of the material [9]. However, this conversion reaction is never complete with residual monomers and degree of conversion ranging, for example, between 50 and 80% for composite resins, allowing the leaching of non-polymerized monomers [9]. High concentrations of substances released can lead to cytotoxic effects [8,10], genotoxic effects [10] or allergic effects [11]. However, the quantity of substances released would be too low to induce systemic toxicity [8,10,11].
Among components likely to be released, BPA, an organic compound listed as an endocrine disruptor by European commission [12] retains a particular attention because it may alter patients’ health at very low doses [13]. BPA is commonly used in the industrial production of polycarbonate plastics and epoxy resins [12]. In dentistry, BPA is never found in a pure state in resin-based materials, but it can be released in oral cavity [14] because it is the precursor of certain monomers used in their composition such as BisGMA, Bisphenol A dimethacrylate (BisDMA), Ethoxylated bisphenol A glycol dimethacrylate (BisEMA), Polycarbonate-modified BisGMA (PC BisGMA) and 2,2-bis[(4-methacryloxy polyethoxy)phenyl]propane (BisMPEPP) [14,15,16,17,18,19]. BPA may be detected in plasma and saliva of patients treated with resins leaching monomers-derived residues [14,15,16,17,18,19].
The BPA found from resin-based dental materials can come either from impurities in the synthesis of BPA derivatives monomers or from their degradation over time [14,15,16,17,18,19]. However, among BPA derivatives, only the cleavage of BisDMA by salivary esterases can directly form BPA [15,16]. For this reason, BisDMA is almost no longer used in dental resin materials.
Numerous experimental and epidemiological studies established the causal link between exposures to endocrine disrupting chemicals, including BPA, and the development of certain pathologies [12,20] such as male and female infertility, early puberty in girls, breast, testicular or prostate cancer, metabolic disorders (type II diabetes, obsesity etc) neurodevelopmental damage and behavioral disorders, or even enamel hypomineralising pathologies [21]. Infants, young children, teenagers during puberty, pregnant and lactating women are the most sensitive to exposures to BPA [12]. Despite BPA contamination may occur through dermal, respiratory, placental routes, the main contamination occurs through oral route with alimentation and drinks containing BPA [12]. It is the reason why the European Commission has banned BPA from the manufacturing of baby bottles since 2011, from plastic bottles and packaging containing foods for children under 3 years old since February 2018 and thermal paper since January 2020 [12]. In 2023, the European Food Safety Authorities (EFSA) reduced the Tolerable Daily Intake (TDI) from 4 mg/kg/day to 0.2 ng/kg/day (20 000 times less than the last TDI) because of possible BPA low-dose effects [12].
To date, there is no study focused on the monomer composition of all categories of resin-based dental materials currently on the market that would help to evaluate the appropriate use of these materials. The available studies are mainly focused on only one category of materials, mainly composite resins, or adhesive systems [1,18]. The goal of this study was first to detail the monomer composition of resin-based dental materials sold in the market in 2023 and second, to evaluate the percentage of materials with BPA derivatives in their manufacturing in relation with their applications.

2. Materials and Methods

2.1. Materials Studied

To reference an exhaustive list of resin-based dental materials sold in the global market, a search was co ducted on the manufacturers’ websites. The following categories of dental materials were selected:
-
Restorative composite resins
-
Orthodontic composite resins
-
Core build up composite resins
-
Restorative and orthodontic adhesive systems
-
Sealants
-
Restorative resin modified glass ionomer cements
-
Luting glass ionomer cements and composites

2.2. Search Strategy

Next, for all the materials found, chemical composition was searched on the material safety data sheet (MSDS), when available, to reference all monomers contained in material composition. When the information was not available on MSDS or on manufacturer website, a complementary search was conducted on PubMed database (National Library of Medicine) to identify studies with information on monomers composition of selected materials.

2.3. Data Analysis

All results were recorded and analyzed by using Microsoft Excel 2016 software (Microsoft, WA, USA). Percentages were carried out to analyze the results for each material category. Then, the results were summarized in tables.

3. Results

3.1. Materials Identified and Source of Information

In 2023 a total of 743 resin-based dental materials were identified from 52 companies respectively:
-
305 restorative composite resins
-
49 core build up composite resins
-
66 orthodontic composite resins
-
142 restorative adhesive systems
-
33 orthodontic adhesive systems
-
32 sealants
-
16 Resin modified glass ionomer cements
-
100 luting cements and composites.
Among all resin-based dental materials identified, 141 (19%) had insufficient information about their monomer composition, 59 (7.9%) materials identified had no information about their monomer composition. As a result, the percentages were calculated considering the 543 products from 44 companies with known composition (Table 1).
When information was incomplete, the following terms were the most frequently mentioned in MSDS: “methacrylates”, “blend of multifunctional methacrylates”, “hydrophobic aromatic dimethacrylate”, “hydrophobic aliphatic dimethacrylate”, “uncured methacrylate ester monomers”, “acid adhesive monomer”, “hydrophilic aliphatic methacrylate”, “acidic monomer” (Table 2).

3.2. Monomers Identified

In total, 59 monomers were found in chemical composition of all materials and 6 were BPA derivatives (Table 3). 1 composite resin contained silorane and 5 composite resins contained ormocer resin matrix.
Among all materials included in the final analysis (543 materials), 382 materials (70.3%) contained BPA derivatives. Among them, 305 (56.2%) contained BisGMA, 152 (28%) contained BisEMA, 17 (3.1%) contained BisMPEPP, 8 (1.5%) contained BisDMA, 3 (0.6%) contained BisPMA and 2 (0.4%) contained PC BisGMA.
161 materials (29.7%) contained no BPA derivatives. Among all no BPA-derivatives monomer identified, UDMA, TEGDMA and HEMA were the most common in all resin-based materials categories. 309 materials (56.9%) contained UDMA, 292 (53.8%) contained TEGDMA, 134 (24.7%) contained HEMA. 21 materials (3.9%) contained no BPA derivatives and no UDMA, TEGDMA and HEMA (Table 4). The highest proportion of BPA-derivatives materials was found in composites (78.7 to 83.8%). Some materials still contained BisDMA such as 10.5% orthodontic adhesives and 8.3% sealants.

4. Discussion

In this study, an exhaustive list of 743 resin-based materials currently marketed from 52 companies was drawn up. Among them, 543 are provided with a complete composition list and were included in the study for final analysis.

4.1. Source of Information

Patients may ask their practitioner about the nature and safety of materials placed in their oral cavity especially concerning possible BPA derivatives. Practitioners have a duty to inform and protect their patients. This means, they must know the chemical composition of all the materials used for traceability requirements.
In this study, the composition of each category of resin-based dental materials identified was well established. Among the 743 materials initially found, 141 (19%) had insufficient information about their monomer composition and only 59 (7.9%) had no information about their monomer composition. It was thus possible to work on 543 products. In fact, sometimes manufacturers are reluctant to reveal all the components in their products due to commercial reasons and trade secrets. Currently, there is no obligation to indicate the exact composition of materials unlike what it is required for drugs. Material Safety Data Sheet (MSDS) of a product should give information on all its components with a proportion above 1% (REACH Regulation (EC) n° 1907:2006 in European Union, OSHA Hazard Communication Regulations n° 1910.1200g8 for the United States). However, this study showed that several MSDS forms indicate only part of the composition, mentioning only the family of molecules like “methacrylates”, “hydrophobic aliphatic dimethacrylate” or “hydrophobic aromatic dimethacrylate”. In addition, some components may have undesirable long-term effects on health despite their presence at low-doses when released chronically during years. That’s why it is important that manufacturers provide the complete and precise list of potentially active substances (even if present < 1%).

4.2. Concerns on BPA Derivatives Monomers

Our study indicates that most dental materials (70.3%) sold in 2023 still contains BPA-derivatives monomers. It is generally admitted that BPA leached from dental material isn’t likely to pose a threat to human health [18,19], the situation should be analyzed carefully with more details. In fact, the most used dental materials, especially for care of children and teenagers, such as restorative composites, orthodontic composites and adhesives and sealants, are the most susceptible to contain BPA-derivatives monomers, for 83.8%, 78.7%, 63.2%, and 66.7% of them respectively. BisGMA was the most often reported BPA derivative (56.2%) except for resin-modified glass ionomer cements. BisEMA, is the second BPA derivative most frequently present with 28.1% of dental materials, in all categories of materials except adhesives.
The release of BPA from resin-based dental materials is described in the literature both in vitro in organic solvents or artificial saliva and clinically in saliva or urine [14,15,16,17,18,19,22,25]. The data in the literature show a great heterogeneity of BPA levels which vary from one study to another [14,15,16,17,18,19,22,25]. In fact, BPA levels depend on analysis techniques, extraction solutions, fixed detection thresholds or other experimental conditions which make studies difficult to compare [15,16,24]. For example, with GC/MS (Gaz chromatography/Mass Spectrometry) technique, the application of heat can overestimate the concentrations of BPA released because it accelerates the process of degradation of BPA derivatives monomers into BPA [15,16,24]. Also, measurements of BPA levels are performed at different times after the starting of the in vitro degradation procedure with a maximum of elution found after 24h [14,15,16,17,18,19,22,25].
Reported quantity of BPA measured in patients’ saliva are generally higher than those released in vitro in artificial saliva or buffers (around 10 to 100 times higher) [15,24]. As a reminder, BPA levels in patients’ saliva reported in the first paper of Olea and co-workers were from 3 to 30 mg/mL [14] whereas a recent study evaluating the BPA release immediately after composite resin filling in adults found much lower BPA levels with a mean level at 0.11 ng/mL [23]. Like in vitro studies, clinical studies are difficult to compare. Studies that do not present an acidification step in their saliva recovery procedure can overestimate the BPA found due to the process of degradation of BPA derivatives monomers into BPA which is accelerated without this acidification step [23]. Furthermore, individual factors can influence the amount of BPA in saliva including patients’ lifestyle, the respect of the instructions before saliva samples collecting, the metabolism of molecules by the salivary enzymes and the volume of resin material used [23].
The BPA leached from resin-based dental materials can come either from impurities in the synthesis of monomers in their chemical composition or from the degradation of BPA-derivatives monomers over time (only BisDMA cleavage by salivary esterases can release pure BPA) [14,15,16,17,18,19]. BisDMA is relatively rare in resin-based dental materials that is confirmed by our study (1.5% of all dental materials). However, when considering the situation more carefully, its presence was still found in 10.5% of orthodontic adhesives and 8.3% of sealants. For example, a study shows a cumulative BPA level in saliva of 0.09 ng during the first 24 hours from four dental sealants (4 sealants corresponding to 32 ng of resin used) [25]. Although the BPA levels reported in literature are generally below the tolerable daily intake (up to 2 ng for 6 years-old children weighing 20 kg according to the recently TDI set by EFSA), these data are surprising because they concern young people, a population more susceptible to long-term effects of environmental toxicants even at low doses[12,13,20].
Despite BisDMA is generally admitted as the sole BPA-derivative monomer able to release BPA, De Nys et al showed a conversion rate in BPA in artificial saliva at 0.0003% for BisGMA, at 0.0017% for one type of BisEMA16. These values could seem relatively low but these two monomers are the most widespread in dental materials (for BisGMA around 10-25% of weight in resin matrix of certain restorative composites), they thus represent a non-negligible amount of BPA possibly released.
The major health impacts and concerns of BPA are linked to its endocrine disrupting activity after years of chronic exposure [12,20]. Certain periods of life should be considered with precaution: pregnancy with fetal organ development, newborn stage due to tissue immaturity and adolescents during puberty with the maturation of sexual organs (around 12-15 years old for boys and 10-12 years old for girls) [12,20]. However, due to transgenerational BPA activity, all individuals eligible for procreation should be considered carefully, which enlarges the period of critical time for BPA exposure [26]. In addition to the window time of exposure, the dose of exposure must also be considered as BPA may have greater effects at low doses than high doses without a threshold dose contrary to the classic pattern encountered in toxicology [27]. Recently, the European Food Safety Authority decided to reduce the Tolerable Daily Intake allowed to 0.2 ng/kg/day that is lower than BPA levels detected in saliva after resin placement in oral cavity [12]. This point should be considered for recommendation of materials completely devoid of BPA-derivatives monomers placed for years in the oral cavity. The continual chronic leaching of monomers able to be degraded into BPA, even at very low-dose, may have side long-term effects on patients’ health [20,21,26]. In addition, as BPA sublingual passage into circulation is possible, it may be immediately active on target tissues [28].

4.3. Other Types of Monomers

161 of the 543 resin-based dental materials analyzed by this study (29.7%) contained no BPA-derivatives monomers. BPA is not the only potentially toxic components in resin-based dental materials, other monomers could be toxic. The release of UDMA, TEGDMA and HEMA is often reported in the literature whether in vitro in organic solvents or artificial saliva and clinically in saliva [9,15,24,29]. Among the 53 monomers not BPA derivatives, 3 are mainly found in the chemical composition of the different categories of materials studied: UDMA, TEGDMA and HEMA.
In the context of resin-based materials, it is recognized that the presence of unpolymerized monomers can cause toxic biological effects such as cytotoxicity, estrogenicity, genotoxicity or allergic reactions [8,10]. These effects are rarely immediate. Furthermore, the higher the degree of polymerization is, the less toxic biological effects would be observed [8,10].
Some authors demonstrated adverse effects depending on the presence of TEGDMA, HEMA or UDMA [30,31,32,33,34,35]. UDMA is a monomer commonly added in dental resin-based dental materials to enhance their viscosity and is considered to an alternative to BisGMA in these materials [1,2]. A recent meta-analysis reported UDMA toxicity on fibroblasts or mesenchymal cells just below BPA but higher than TEGDMA and HEMA [30]. Resin-matrix cements cause a cytotoxic reaction when in contact with fibroblasts or mesenchymal cells due to the release of monomers from the polymeric matrix. The amounts of monomers released from the resin matrix and their cytotoxicity depend on the polymerization parameters [30]. UDMA was found in all categories of materials screened in this study and was the most widespread monomer in sealants and luting cements and composites. UDMA presents some cell toxicity and genotoxic effects for some cell types (pulp cells, human gingival fibroblasts or even macrophages) [30,31,32]. These effects occur even at a very low UDMA concentrations suggesting low-dose effects of this monomer on health comparable to BPA earlier discussed [31]. However, often, UDMA used in resin-based materials is in a modified form, as mentioned in certain MSDS (Aromatic Urethane Dimethacrylate (AUDMA), urethane methacrylate oligomer or UDMA modified). Modified UDMA should be further investigated for their cellular activities as no data is available to date concerning their possible low-dose and long-term effects.
TEGDMA is a low molecular mass monomer often added into resin-bases dental materials matrix to reduce the viscosity of the mixture [1,2]. In this study, it was present in all categories of materials except RMGICs and was the second monomer most frequently found in orthodontic composite resins and luting cements and composites. It has been reported that TEGDMA presents cytotoxic, genotoxic, and estrogenic effects for different cell types such as pulp cells, human gingival fibroblasts and monocytes but at a lower level than UDMA [32,33]. TEGDMA, contrary to UDMA, is also able to activate estrogen receptor alpha at low-doses like for BPA and BPA derivatives [34].
HEMA is a low molecular mass monomer with hydrophilic character. It is frequently added to the resin matrix of adhesive systems and luting cements and composites [1,2]. HEMA is the monomer used in resin matrix of RMGICs [3]. Accordingly, HEMA was also found the most frequently in adhesive systems and RMGICs. HEMA may present some cell toxicity and genotoxic effects but much lower than BPA, BPA derivatives, UDMA or TEGDMA [35].
Finally, the combination of certain monomers could increase cytotoxic and genotoxic effects observed as has been shown in the case of the combination of TEGDMA with UDMA often found in resin-based materials [32]. However, concerning monomers toxicity there are only few clinical studies and studies are mainly carried out in vitro. This does not fully reflect the conditions of the oral environment, particularly the role of saliva. Moreover, biological effects observed in all studies are quite slight [8,9,10,30,31,32,33,34,35].

4.4. Clinical Recommendations

All studies on activity of monomers released from dental material lead to propose a limited exposure to unpolymerized resin-based dental materials and to select materials without BPA derivatives for children and teenagers. The same precautions must be taken for pregnant and lactating women. Some clinical procedures could be applied to minimize the release of unpolymerized monomers [15,16,17,18,19,36,37]: rubber dam use for restorations making, using a curing lamp with sufficient power (>1000 mW/cm2), bring the fiber of the curing lamp closer to the material to be cured and prolonged curing time or in case of restoration making a second curing step after covering the restoration with a glycerin film. Unpolymerized monomers are present on the surface of the material because the inhibition of polymerization induced by oxygen [36,37]. It was also demonstrated that brushing the restoration surface with pumice or water/air spray eliminated most residual monomers [36,37]. Garling with warm water 30 s after orthodontic bonding [18] or restoration bonding [37] could also reduce the level of residual monomers. Finally, using indirect or CAD-CAM resin materials for restorations could also minimize the monomer release with maximum degree of conversion for these types of materials [38].
Despite, the part of the overall BPA exposure dose coming from oral intake linked to dental materials, is difficult to evaluate precisely, the contribution of dental materials to overall BPA contamination is not negligible. When considering the possible cocktail effects, in individuals chronically exposed to a multitude of toxic substances, these substances, combined with each other, may have greater undesirable effects for the body, increasing the concerns on dental materials containing BPA-derivatives monomers [39]. According to the last TDI for BPA established recently by EFSA, BPA is formerly banned from the environment of Europeans [12]. To limit the exposure of patients to components likely to release BPA, some manufacturers developed alternative substitues of BPA as bisphenol S or bisphenol F also classified as endocrine disruptors based on studies showing similar effects than BPA [40]. An alternative was resin-based dental materials without BPA derivatives but still containing other types of monomers such as UDMA or TEGDMA [15,16]. Another alternative could be using materials without resin for restoration making or orthodontic bonding such as high viscosity glass ionomers and ceramic (for restorations).

5. Conclusions

Despite it may generally be admitted that resin-based dental materials are of no concern for human health, it is necessary to carefully analyze their composition to evaluate their hazard and risk for specific population to propose recommendation for patient care.
This study has established an exhaustive list of 543 resin-based dental materials from 44 companies. Among their chemical composition, 59 monomers were found with 6 being BPA derivatives. More than 70% materials, including composite resins and adhesive systems for restorative dentistry and orthodontics, sealants, luting cements and composites and RMGICs, contain BPA derivatives monomers. More importantly, some materials mostly used for young populations such as composite resins and adhesives for restorative dentistry and orthodontics still contain BisDMA able to release BPA. The long-term effects on human health of the different monomers identified, BPA in particular, are now well established. That’s why, considering possible health impact of BPA-derived monomers whatever their levels of release in patient body, practitioners should opt for alternative materials that do not contain any BPA-derived monomers and at least, materials provided with an MSDS listing exact chemical composition, like for drugs.
This precautionary recommendation would be the responsibility of dentists and the competent health authorities.

Supplementary Materials

The following supporting information can be downloaded at the website of this paper posted on Preprints.org., Table S1: manufacturers and number of materials first identified for each category.

Author Contributions

Conceptualization, JP.A. and S.B.; methodology, CA.D.; validation, JP.A., J.B. and S.B.; investigation, CA.D.; data curation, CA.D.; writing—original draft preparation, CA.D., J.B. and S.B.; writing—review and editing, CA.D., S.B., A.N., S.H., K.J., P.F., E.D., JP.A. and J.B.; visualization, CA.D.; supervision, S.B., JP.A. and J.B. All authors have read and agreed to the published version of the manuscript.

Funding

Not applicable.

Institutional Review Board Statement

Not applicable

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Pratap B, Gupta RK, Bhardwaj B, Nag M. Resin based restorative dental materials: characteristics and future perspectives. Jpn Dent Sci Rev. 2019, 55, 1, 126-138. [CrossRef]
  2. Dressano D, Salvador MV, Oliveira MT, Marchi GM, Fronza BM, Hadis M, et al. Chemistry of novel and contemporary resin-based dental adhesives. J Mech Behav Biomed Mater. 2020, 110, 103875. [CrossRef]
  3. Sidhu SK, Nicholson JW. A review of glass-ionomer cements for clinical dentistry. J Funct Biomater. 2016, 7, 3, 16. [CrossRef]
  4. Naaman R, El-Housseiny AA, Alamoudi N. The use of pit and fissure sealants-a literature review. Dent J (Basel). 2017, 5, 4, 34. [CrossRef]
  5. Kuśmierczyk D, Małkiewicz K. Orthodontic adhesive systems –over half a century of research and experience. J Stomatol. 2019, 2, 4, 179-183. [CrossRef]
  6. Heboyan A, Vardanyan A, Karobari MI, Marya A, Avagyan T, Tebyaniyan H, et al. Dental luting cements: an updated comprehensive review. Molecules. 2023, 28, 4, 1619. [CrossRef]
  7. Tsujimoto A, Barkmeier WW, Fischer NG, Nojiri K, Nagura Y, Takamizawa T et al. Wear of resin composites: current insights into underlying mechanisms, evaluation methods and influential factors. Jpn Dent Sci Rev. 2018, 54, 2, 76-87. [CrossRef]
  8. Shahi SM, Özcan M, Maleki Dizaj S, Sharifi S, Al-Haj Husain N, Eftekhari A et al. A review on potential toxicity of dental material and screening their biocompatibility. Toxicol Mech Methods. 2019, 29, 5, 368–77. [Google Scholar] [CrossRef]
  9. Pongprueksa P, Munck JD, Duca RC, Poels K, Covaci A, Hoet P, et al. Monomer elution in relation to degree of conversion for different types of composites. J. Dent. 2015, 43, 12, 1448–55. [Google Scholar] [CrossRef]
  10. Romo-Huerta MJ, Cervantes-Urenda ADR, Velasco-Neri J, Torres-Bugarín O, Valdivia ADCM. Genotoxicity associated with residual monomers in restorative dentistry: a systematic review. Oral Health Prev Dent. 2021, 19, 1, 471-480. [CrossRef]
  11. Syed M, Chopra R, Sachdev V. Allergic reactions to dental materials-a systematic review. J Clin Diagn Res. 2015, 9, 10, ZE04-9. [CrossRef]
  12. EFSA CEP Panel (EFSA Panel on Food Contact Materials, Enzymes and Processing Aids), Lambré C, Barat Baviera JM, Bolognesi, C, Chesson A, Cocconcelli PS, et al. Scientific Opinion on the re-evaluation of the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs. EFSA Journal. 2023, 21, 4, 6857, 392.
  13. Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS et al. EDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals. Endocr Rev. 2015, 36, 6, E1–E150. [CrossRef]
  14. Olea N, Pulgar R, Pérez P, Olea-Serrano F, Rivas A, Novillo-Fertrell A, et al. Estrogenicity of resin-based composites and sealants used in dentistry. Environ Health Perspect. 1996, 104, 3, 298-305. [CrossRef]
  15. De Angelis F, Sarteur N, Buonvivere M, Vadini M, Šteffl M, D'Arcangelo C. Meta-analytical analysis on components released from resin-based dental materials. Clin Oral Investig. 2022, 26, 10, 6015-6041. [CrossRef]
  16. De Nys S, Duca RC, Vervliet P, Covaci A, Boonen I, Elskens M, et al. Bisphenol A as degradation product of monomers used in resin-based dental materials. Dent Mater. 2021, 37, 6, 1020-1029. [CrossRef]
  17. Lopes-Rocha L, Ribeiro-Gonçalves L, Henriques B, Özcan M, Tiritan ME, Souza JCM. An integrative review on the toxicity of Bisphenol A (BPA) released from resin composites used in dentistry. J Biomed Mater Res B Appl Biomater. 2021, 109, 11, 1942-52. [CrossRef]
  18. Dursun E, Fron-Chabouis H, Attal JP, Raskin A. Bisphenol A release: survey of the composition of dental composite resins. Open Dent J. 2016, 10, 446-453. [CrossRef]
  19. Małkiewicz K, Turło J, Marciniuk-Kluska A, Grzech-Leśniak K, Gąsior M, Kluska M. Release of bisphenol A and its derivatives from orthodontic adhesive systems available on the European market as a potential health risk factor. Ann Agric Environ Med. 2015, 22, 1, 172–7. [Google Scholar] [CrossRef]
  20. Ma Y, Liu H, Wu J, Yuan L, Wang Y, Du X. The adverse health effects of bisphenol A and related toxicity mechanisms. Environ Res. 2019, 176, 108575. [Google Scholar] [CrossRef] [PubMed]
  21. Jedeon K, De la Dure-Molla M, Brookes SJ, Loiodice S, Marciano C, Kirkham K et al. Enamel defects reflect perinatal exposure to bisphenol A. Am J Pathol. 2013, 183, 1, 108–18. [Google Scholar] [CrossRef]
  22. Maserejian NN, Trachtenberg FL, Wheaton OB, et al. Changes in urinary bisphenol A concentrations associated with placement of dental composite restorations in children and adolescents. J Am Dent Assoc. 2016, 147, 8, 620–30. [Google Scholar] [CrossRef]
  23. Berge TLL, Lygre GB, Jönsson BAG, Lindh CH and Björkman L, 2017. Bisphenol A concentration in human saliva related to dental polymer-based fillings. Clin Oral Investig. 2017, 21, 8, 2561–2568. [CrossRef]
  24. Hampe T, Wiessner A, Frauendorf H, Alhussein M, Karlovsky P, Bürgers R, et al. Monomer Release from Dental Resins: the current status on study setup, detection and quantification for in vitro testing. Polymers (Basel). 2022, 14, 9, 1790. [CrossRef]
  25. ADA professional product review. Bisphenol A released from resin based dental sealants. 2016, 11, 1.
  26. Jung YH, Wanga HLV, Ruiza D, Bixlera BJ, Linsenbauma H, Xianga JF et al. Recruitment of CTCF to an Fto enhancer is responsible for transgenerational inheritance of BPA-induced obesity. PNAS. 2022, 119, 50, e2214988119. [CrossRef]
  27. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr, Lee DH, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev. 2012, 33, 3, 378-455. [CrossRef]
  28. Gayrard V, Lacroix MZ, Collet SH, Viguié C, Bousquet-Melou A, Toutain PL et al. High bioavailability of bisphenol A from sublingual exposure. Environ Health Perspect. 2013, 21, 8, 951-56. [CrossRef]
  29. Barišić ML, Sarajlija H, Klarić E, Knežević A, Sabol I, Pandurić V. Detection of leachable components from conventional and dental bulk-fill resin composites (high and low viscosity) using liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. Polymers (Basel). 2023, 15, 3, 627. [CrossRef]
  30. Chang CY, Chiang CY, Chiang YW, Lee MW, Lee CY, Chen HY, et al. Toxic effects of urethane dimethacrylate on macrophages through caspase activation, mitochondrial dysfunction, and reactive oxygen species generation. Polymers (Basel). 2020, 12, 6, 1398. [CrossRef]
  31. Chang HH, Chang MC, Wang HH, Huang GF, Lee YL, Wang YL, et al. Urethane dimethacrylate induces cytotoxicity and regulates cyclooxygenase 2; hemeoxygenase and carboxylesterase expression in human dental pulp cells. Acta Biomater. 2014, 10, 722–731. [CrossRef]
  32. Wisniewska-Jarosinska M, Poplawski T, Chojnacki CJ, Pawlowska E, Krupa R, Szczepanska J, et al. Independent and combined cytotoxicity and genotoxicity of triethylene glycol dimethacrylate and urethane dimethacrylate. Mol Biol Rep. 2011, 38, 7, 4603. [CrossRef]
  33. Nilsen BW, Simon-Santamaria J, Örtengren U, Jensen E, Bruun JA, Michelsen VB, et al. Dose- and time-dependent effects of triethylene glycol dimethacrylate on the proteome of human THP-1 monocytes. Eur J Oral Sci. 2018, 126, 5, 345-358. [CrossRef]
  34. Seo H, Ahn YJ, Seo H, Seo A, Lee H, Lee SH, et al. Comprehensive assessment of the estrogenic activity of resin composites. Chemosphere. 2023, 343, 140104. [Google Scholar] [CrossRef] [PubMed]
  35. Gallorini M, Cataldi A, di Giacomo V. HEMA-induced cytotoxicity: oxidative stress, genotoxicity and apoptosis. Int Endod J. 2014, 47, 9, 813–818. [Google Scholar] [CrossRef]
  36. Komurcuoglu E, Olmez S, Vural N. Evaluation of residual monomer elimination methods in three different fissure sealants in vitro. J Oral Rehabil. 2005, 32, 2, 116–121. [CrossRef]
  37. Tkáčiková S, Sabo J. Release of monomers from dental composite materials into saliva and the possibility of reducing the toxic risk for the patient. Medicina. 2023, 59, 7, 1204. [CrossRef]
  38. Hampe T, Liersch J, Wiechens B, Wassmann T, Schubert A, Alhussein M, et al. A pilot study on monomer and bisphenol A (BPA) release from UDMA-based and conventional indirect veneering composites. Polymers (Basel). 2022, 14, 21, 4580. [CrossRef]
  39. Whyatt RM, Rundle AG, Perzanowski MS, Just AC, Donohue KM, Calafat AM et al. Prenatal phthalate and early childhood bisphenol A exposures increase asthma risk in inner-city children. J Allergy Clin Immunol 2014;134(5):1195-1197. [CrossRef]
  40. Reina-Pérez I, Olivas-Martínez A, Mustieles V, Ruiz-Ojeda FJ, Molina-Molina JM, Olea N, et al. Bisphenol F and bisphenol S promote lipid accumulation and adipogenesis in human adipose-derived stem cells. Food Chem Toxicol. 2021, 152, 112216.
Table 1. Manufacturers and number of materials identified for final analysis.
Table 1. Manufacturers and number of materials identified for final analysis.
Manufacturer Restorative composite resins Core build up composite
resins		 Orthodontic
composite
resins		 Restorative
adhesive
systems		 Orthodontic
adhesive
systems		 Sealants RMGICs Luting
cements and composites
Apol 5 / / 1 / / / /
American
orthodontics 		/ / 1 / 1 / / /
Bisico 12 3 / 6 / 1 / 4
BJM / / 2 / 1 / / /
Cavex 3 / / 2 / / / /
Coltene 11 1 / 5 / / / 3
Cosmedent 8 1 / / / 2 / 2
CyberTech 2 1 / / / / / /
Dentaurum / / 3 / / / / /
DenMat 2 1 / 6 / 1 2 /
Dental
Technologies 		5 2 2 4 1 2 / 2
Dentsply 14 2 / 4 / 1 / 3
DMG 6 2 / 4 / / / 2
Exotec 2 / / / / / / /
FGM 5 1 / / / / / 2
GC 20 1 2 3 / / 2 10
Gestenco / / 1 / / / / /
Henry Schein 7 / / 2 / 1 / 1
Itena 2 1 / 2 / 1 / 3
Ivoclar-Vivadent 15 2 1 7 / 4 / 4
Jeneric Pentron 5 2 / 2 / / / /
Kerr 11 / / 5 / / / 4
Kettenbach Dental 2 / / / / / / 1
Kulzer 15 / / 3 / / / /
Kuraray 6 3 / / / 1 / 1
3M 12 / 6 8 2 2 5 3
Micerium 5 / / / / 1 / 4
Ormco / / 4 / 1 / / /
Ortho
Technology 		/ / 3 / / / / /
Parkell 2 2 / 2 / / / 2
Reliance / / 13 / 10 / / /
RMO / / 3 / 1 / / /
R&S 3 / / 1 / / / /
Saremco 6 / / 4 / 1 / 1
Schütz Dental 8 / / 1 / / / 1
Septodont 7 / / 1 / / / /
Shofu 10 / / / / 1 / 2
SDI 11 / / / / / / /
Sun Medical 3 / / / / / / 1
Tokuyama 11 / / 3 / / / 2
TP Orthodontics / / 1 / 1 / / /
Ultradent 3 1 2 3 / 2 / 4
Vericom / / 1 / 1 / / /
Voco 27 3 2 2 / 4 1 5
Total 266 29 47 81 19 24 10 67
Table 2. The different terms mentioned in MSDS when monomer composition was incomplete.
Table 2. The different terms mentioned in MSDS when monomer composition was incomplete.
Terms mentioned in MSDS (composition incomplete) Number of materials concerned
Blend of multifunctional methacrylates 6
Hydrophobic aromatic dimethacrylate 10
Hydrophobic aliphatic dimethacrylate 6
Aliphatic dimethacrylate 2
Uncured methacrylate ester monomers 7
Uncured methacrylate resin mixture 2
Other bifunctional methacrylate monomers 1
Hydrophilic dimethacrylates 4
Aromatic dimethacrylate 1
Aliphatic trimethacrylate 1
Methacrylates 18
Matrix of methacrylic monomers 1
Phosphatic methacrylate monomer 2
Mixture of uncured methacrylate ester monomers 2
Other 3
Acid adhesive monomer 6
Methacrylate ester monomer 1
Polymerizable dimethacrylate resin 1
Polymerizable trimethacrylate resin 1
acidic and hydrophilic methacrylic monomers 2
Trade secret 3
Acrylates 2
Acrylic monomers 4
Phosphonic acid type monomer 2
Carboxilic acid type monomer 2
Phosphoric acid monomer 4
Citric acid methacrylate oligomer 1
Multifunctional monomers 1
hydrophobic aromatic methacrylate 1
Uncured acrylate ester monomers 4
Acidic monomer 6
Dimethacrylate cross linker 3
Copolymer of acrylic and itaconic acid 3
Proprietary methacrylate 1
Hydrophilic acidic monomer 2
Mixture of methacrylate monomers 1
Dimethacrylates 8
Hydrophilic amide monomer 3
Hydrophilic aliphatic methacrylate 6
Table 3. Monomers found in chemical composition of all materials. List of their name and/or chemical name.
Table 3. Monomers found in chemical composition of all materials. List of their name and/or chemical name.
Monomer abbreviation Monomer name and/or chemical name
BisGMA Bisphenol A Glycidyl Methacrylate or 2,2-bis[4-(3-methacryloxy-2-hydroxypropoxy)phenyl]propane
PC BisGMA Polycarbonate-modified bis-GMA
BisDMA Bisphenol A Dimethacrylate or 2,2-bis-(4-(methacryloxy) phenyl) propane
BisEMA or EBPADMA or E2BADMA Ethoxylated Bisphenol A glycol dimethacrylate
BisMPEPP or BPEDMA Bisphenol A polyethoxy dimethacrylate or 2,2-bis(4-methacryloxy poly-ethoxyphenyl)propane
BisPMA Propoxylated Bisphenol A-Dimethacrylate
BisGDMAP Bis(Glyceryl Dimethacrylate) Phosphate or 2-methacryl acid phosphinicobis (oxy-2,1,3-propanetriyl) ester
UDMA/UDMA modified Urethane dimethacrylate or 1,6-di(methacryloyloxyethylcarbamoyl)-3,3,5-trimethylhexane
UTMA Urethane trimethacrylate
AUDMA Aromatic urethane dimethacrylate
TEGDMA Triethylene glycol dimethacrylate
TEDMA Triethylene dimethacrylate
DEGDMA Diethylene glycol dimethacrylate
EGDMA Ethylene glycol dimethacrylate
PEGDMA Polyethylene glycol dimethacrylate
PEGDA Polyethylene glycol diacrylate
PMMA Polymethyl methacrylate
MMA Methyl methacrylate
HEMA Hydroxyethyl methacrylate or -Propenoic acid, 2-methyl-,2-hydroxyethyl ester or 2-hydroxyethyl methacrylate
HPMA 2-Hydroxypropyl methacrylate
GDMA Glycerol dimethacrylate
GMA Glycidyl methacrylate
GPDM Gycerol phosphate dimethacrylate
DMAEMA 2-(Dimethylamino)ethyl methacrylate or Methacrylic acid 2-(dimethylamino)ethyl ester
BDDMA 1,4- Butanediol Dimethacrylate or Tetramethylene dimethacrylate
THFMA Tetrahydrofurfuryl methacrylate or 2-Propenoic acid, 2-methyl-, (tetrahydro-2-furanyl)methyl ester
TMPTMA Trimethylolpropane trimethacrylate
TMPTA Triméthyllolpropane triacrylate or 2-propenoic acid, 2-ethyl-2-((1-oxo-2-propenyl)oxy)methyl)-1,3--propanediyl ester
TMPSM or TMSPMA 3-(Trimethoxysilyl)propyl methacrylate or 3-Methacryloxypropyltrimethoxysilane
HDODA 1,6-Hexanediol diacrylate
4-MET 4-methacryloxyethyl trimellitic acid
4-META 4-methacryloyloxyethy trimellitate anhydride
10-MDP 10-Methacryloyloxydecyl dihydrogen phosphate
MDTP 10-methacryloyloxydecyl dihydrogen thiophosphate
NPG2PODA Neopentyl glycol propoxylate diacrylate
NPGDMA Neopentyl glycol Dimethacrylate or 2,2-dimethylpropane-1,1-diyl bis(2-methylprop-2-enoate)
NTGGMA N-(2-hydroxy-3-((2-methyl-1-oxo-2-propenyl) oxy) propyl)-N-tolyl glycine
TCDDMA or TCDMA Tricyclodecane dimethanol dimethacrylate or 2-propenoic acid,(octahydro-4,7-methano-1h-indene-5,1-diyl)bis(methylene) ester
D3MA decanediol 1,10-dimethacrylate
PCDMA Polycarbonate dimethacrylate
TCD-DI-HEA 2-propenoic acid; (octahydro-4,7-methano-1H-indene-5-diyl) bis(methyleneiminocarbonyloxy-2,1-ethanediyl) ester
DDCDMA Dimer dicarbamate dimethacrylate
LPS monomer proprietary monomer
IBMA Isobutyl methacrylate
PDMA Polybutanediol dimethacrylate 600
PMGDM Pyromellitic dianhydride glycerol dimethacrylate
AMPS 2-Acrylamido-2-methylpropane sulfonic acid ou 2-Acrylamido-2-methylpropane sulfonic acid
BMEP Bis[2-(methacryloyloxy)ethyl] phosphate
PENTA Dipentaerythritol penta-acrylate phosphate
MPTMS 3-Mercaptopropyl trimethoxysilane
PMDM Pyromellitic dimethacrylate
TCDDA Tricyclodecane dimethanol diacrylate or Tricyclo[5.2.1.02,6]decanedimethanol diacrylate
AHPM 3-(acryloyloxy)-2- hydroxypropyl methacrylate
PPTTA ethoxylated (5.0) pentaerythritol tetraacrylate
AFM Proprietary monomer
SDR Proprietary monomer
DDDMA 1,12-Dodecanediol dimethacrylate or 12-(2-methylprop-2-enoyloxy)dodecyl 2-methylprop-2-enoate
HDMA or HDDMA or HEDMA 1,6 Hexanediol dimethacrylate
ETPTA Trimethylolpropane ethoxylate triacrylate
Table 4. Monomer composition for all categories of resin-based materials included in the analysis.
Table 4. Monomer composition for all categories of resin-based materials included in the analysis.
Monomer
Composition		 Restorative composite Core build
up composite		 Orthodontic composite Restorative
adhesive		 Orthodontic
adhesive		 Sealants RMGICs Luting
cements and composites		 Total
With BPA
derivatives 		223 (83.8%) 24 (82.8%) 37 (78.7%) 36 (44.4%) 12 (63.2%) 16 (66.7%) 3 (30%) 31 (46.3%) 382 (70.3%)
With BisGMA 177 (66.5%) 20 (69%) 29 (61.7%) 31 (38.3%) 11 (57.9%) 12 (50%) 0 25 (37.3%) 305 (56.2%)
With BisEMA 109 (41%) 11 (37.9%) 7 (14.9%) 5 (6.2%) 2 (10.5%) 3 (12.5%) 3 (30%) 12 (17.9%) 152 (28%)
With BisDMA 1 (0.4%) 0 1 (2.1%) 2 (2.5%) 2 (10.5%) 2 (8.3%) 0 0 8 (1.5%)
With BisMPEPP 15 (5.6%) 0 0 1 (1.2%) 0 0 0 1 (1.5%) 17 (3.1%)
With BisPMA 3 (1.1%) 0 0 0 0 0 0 0 3 (0.6%)
With PC BisGMA 2 (0.8%) 0 0 0 0 0 0 0 2 (0.4%)
With UDMA 188 (70.7%) 14 (48.3%) 12 (25.5%) 27 (33.3%) 7 (36.8%) 15 (62.5%) 4 (40%) 42 (62.7%) 309 (56.9%)
With TEGDMA 175 (65.8%) 23 (79.3%) 20 (42.6%) 20 (24.7%) 6 (31.6%) 11 (45.8%) 1 (10%) 36 (53.7%) 292 (53.8%)
With HEMA 10 (3.8%) 0 6 (12.8%) 71 (87.7%) 10 (52.6%) 3 (12.5%) 9 (90%) 25 (37.3%) 134 (24.7%)
Without BPA derivatives 43 (16.2%) 5 (17.2%) 10 (21.3%) 45 (55.6%) 7 (36.8%) 8 (33.3%) 7 (70%) 36 (53.7%) 161 (29.7%)
Without BPA derivatives or UDMA, TEGDMA and HEMA 7 (2.6%) 0 3 (6,4%) 6 (7.4%) 1 (5.3%) 2 (8.3%) 1 (10%) 1 (1.5%) 21 (3.9%)
Total 266 29 47 81 19 24 10 67 543
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

facebook logotwitter logolinkedin logo
MDPI Initiatives
Important Links
Subscribe

Disclaimer

Terms of Use

Privacy Policy

© 2024 MDPI (Basel, Switzerland) unless otherwise stated